| Are serum interleukin 6 and surfactant protein D levels associated with the clinical course of COVID-19? B Kerget, F Kerget, AO Koçak, A Kızıltunç, Ö Araz, EY Uçar, M Akgün Lung 198, 777-784, 2020 | 87 | 2020 |
| The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients N Kokturk, C Babayigit, S Kul, PD Cetinkaya, SA Nayci, SA Baris, ... Respiratory Medicine 183, 106433, 2021 | 50 | 2021 |
| Evaluation of alpha defensin, IL‐1 receptor antagonist, and IL‐18 levels in COVID‐19 patients with macrophage activation syndrome and acute respiratory distress syndrome B Kerget, F Kerget, A Aksakal, S Aşkın, L Sağlam, M Akgün Journal of medical virology 93 (4), 2090-2098, 2021 | 49 | 2021 |
| Evaluation of the relationship between KIM‐1 and suPAR levels and clinical severity in COVID‐19 patients: A different perspective on suPAR B Kerget, F Kerget, A Aksakal, S Aşkın, EY Uçar, L Sağlam Journal of medical virology 93 (9), 5568-5573, 2021 | 28 | 2021 |
| Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis A Osman Tuberk Toraks 68 (3), 227-235, 2020 | 26 | 2020 |
| Frequency of interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) polymorphisms in COVID-19 patients in Turkey who develop macrophage activation syndrome F Kerget, B Kerget Jpn J Infect Dis 74 (6), 543-548, 2021 | 25 | 2021 |
| Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID‐19 pneumonia A Aksakal, B Kerget, F Kerget, S Aşkın Journal of medical virology 93 (12), 6519-6524, 2021 | 22 | 2021 |
| Is Metrnl an adipokine involved in the anti-inflammatory response to acute exacerbations of COPD? B Kerget, DE Afşin, F Kerget, S Aşkın, M Akgün Lung 198, 307-314, 2020 | 22 | 2020 |
| Sleep disturbances in patients with lung cancer in Turkey Y Bülbül, T ÖzLü, S ArINÇ, B Akinci Ozyurek, H Günbatar, A Senturk, ... Tuberkuloz Ve Torak-Tuberculosis and Thorax 66 (4), 2018 | 21 | 2018 |
| Assessment of palliative care in lung cancer in Turkey Y Bülbül, T Ozlu, S Arinc, BA Ozyurek, H Gunbatar, A Senturk, A Bahadir, ... Medical Principles and Practice 26 (1), 50-56, 2017 | 21 | 2017 |
| Evaluation of 3‐month follow‐up of patients with postacute COVID‐19 syndrome B Kerget, E Çelik, F Kerget, A Aksakal, EY Uçar, Ö Araz, M Akgün Journal of Medical Virology 94 (5), 2026-2034, 2022 | 19 | 2022 |
| Predictive value of mean platelet volume for pulmonary embolism recurrence O Araz, FS Albez, EY Ucar, B Kerget, N Yılmaz, M Akgun Lung 195, 497-502, 2017 | 19 | 2017 |
| Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID‐19 B Kerget, F Kerget, M Aydın, Ö Karaşahin Journal of Medical Virology 94 (5), 1950-1958, 2022 | 18 | 2022 |
| Evaluation of albendazole efficiency and complications in patients with pulmonary hydatid cyst Y Aydin, AB Ulas, I Ince, A Kalin, FK Can, B Gundogdu, K Kasali, B Kerget, ... Interactive CardioVascular and Thoracic Surgery 34 (2), 245-249, 2022 | 18 | 2022 |
| Evaluation of the relationship between TREM‐1/TREM‐2 ratio and clinical course in COVID‐19 pneumonia F Kerget, B Kerget, S İba Yılmaz, A Kızıltunç International journal of clinical practice 75 (10), e14697, 2021 | 17 | 2021 |
| Comparison of long‐term outcomes of 50 and 100 mg rt‐PA in the management of acute pulmonary thromboembolism E Yilmazel Ucar, O Araz, B Kerget, N Yilmaz, M Akgun, L Saglam The clinical respiratory journal 12 (4), 1628-1634, 2018 | 13 | 2018 |
| Comparison of high‐flow and conventional nasal cannula oxygen in patients undergoing endobronchial ultrasonography E Yilmazel Ucar, Ö Araz, B Kerget, M Akgun, L Saglam Internal medicine journal 51 (11), 1935-1939, 2021 | 12 | 2021 |
| Comparison of LMWH versus UFH for hemorrhage and hospital mortality in the treatment of acute massive pulmonary thromboembolism after thrombolytic treatment: randomized … EY Ucar, M Akgun, O Araz, H Tas, B Kerget, M Meral, H Kaynar, L Saglam Lung 193, 121-127, 2015 | 12 | 2015 |
| Acute respiratory distress syndrome after the use of gadolinium contrast agent B Kerget, A Aksakal, DE Afşin, O Araz, EY Ucar, M Akgün, L Sağlam Respiratory medicine case reports 25, 336-338, 2018 | 11 | 2018 |
| Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID‐19 F Kerget, B Kerget, ÇY Kahraman, Ö Araz, M Akgün, EY Uçar, L Sağlam Journal of medical virology 93 (12), 6653-6659, 2021 | 10 | 2021 |
